全文获取类型
收费全文 | 10208篇 |
免费 | 309篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 34篇 |
妇产科学 | 10篇 |
基础医学 | 1154篇 |
临床医学 | 1031篇 |
内科学 | 73篇 |
皮肤病学 | 5篇 |
神经病学 | 4580篇 |
特种医学 | 60篇 |
外科学 | 39篇 |
综合类 | 1522篇 |
预防医学 | 294篇 |
眼科学 | 6篇 |
药学 | 1617篇 |
4篇 | |
中国医学 | 90篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 57篇 |
2022年 | 139篇 |
2021年 | 224篇 |
2020年 | 176篇 |
2019年 | 160篇 |
2018年 | 174篇 |
2017年 | 239篇 |
2016年 | 297篇 |
2015年 | 319篇 |
2014年 | 748篇 |
2013年 | 880篇 |
2012年 | 600篇 |
2011年 | 836篇 |
2010年 | 522篇 |
2009年 | 552篇 |
2008年 | 711篇 |
2007年 | 500篇 |
2006年 | 478篇 |
2005年 | 360篇 |
2004年 | 354篇 |
2003年 | 338篇 |
2002年 | 256篇 |
2001年 | 234篇 |
2000年 | 184篇 |
1999年 | 178篇 |
1998年 | 141篇 |
1997年 | 123篇 |
1996年 | 102篇 |
1995年 | 62篇 |
1994年 | 52篇 |
1993年 | 43篇 |
1992年 | 35篇 |
1991年 | 28篇 |
1990年 | 29篇 |
1989年 | 27篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 25篇 |
1985年 | 41篇 |
1984年 | 41篇 |
1983年 | 31篇 |
1982年 | 33篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 24篇 |
1978年 | 20篇 |
1976年 | 14篇 |
1975年 | 14篇 |
1974年 | 11篇 |
1972年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
精神分裂症异质性及其中枢五羟色胺功能研究 总被引:2,自引:0,他引:2
本文应用高效液相色谱(HPLC)对67例精神分裂症及10例健康对照组脑脊液中色氨酸(TRP)、五羟色胺(5-HT)、五羟吲哚乙酸(5-HIAA)进行测试,同时引入5-HT相对代谢率概念用5-HIAA/5-HT表示,并以Andreasen分型标准划分42例阳性精神分裂症和25例阴性精神分裂症。结果发现,精神分裂症患者脑脊液中TRP明显低于正常对照组,阳性(Ⅰ型)分裂症5-HIAA以及5-HIAA/5-HT明显低于阴性(Ⅱ型)精神分裂症,并对精神分裂症的5-HT代谢障碍假说及其异质性进行了讨论。 相似文献
62.
精神分裂症患者致炎性细胞因子和酪氨酸羟化酶mRNA表达水平的研究 总被引:1,自引:1,他引:0
目的探讨精神分裂症的外周神经免疫机制及其与临床症状的关系。方法检测精神分裂症患者致炎性细胞因子白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF—α)以及酪氨酸羟化酶(TH)的mRNA表达水平,采用逆转录-聚合酶链反应及半定量检测技术,分别检测39例精神分裂症患者(患者组)、25例同胞(同胞组)及30名正常对照(对照组)外周血单个核细胞(PBMC)IL-1β、TNF-α及TH基因表达水平,同时应用阳性和阴性症状量表(PANSS)评定精神分裂症患者临床症状。结果患者组、同胞组及对照组IL-1β的mRNA表达水平分别为1.52±1.01、1.52±1.09和0.74±0.38;TNF—α的mRNA表达水平分别为1.18±0.99、1.01±0.87和0.70±0.29;TH的mRNA表达水平分别为0.55±0.33、0.61±0.32和0.28±0.20。患者组和同胞组的IL-1β、TNF—α、TH的mRNA表达水平均明显高于对照组(P〈0.05或P〈0.01)。患者组IL-1β(r=0.420)、TNF—α(r=0.430)的mRNA表达水平与PANSS的-般病理症状分呈正相关(P〈0.01)。同胞组与对照组合并统计,IL-1β与TNF-α的mRNA表达水平呈正相关(r=0.847,P〈0.01);IL-1β与TH的mRNA表达水平呈正相关(r=0.666,P〈0.01)。患者组仅IL-1β与TNF—α的mRNA表达水平呈正相关(r=0.942,P〈0.01)。结论精神分裂症患者PBMC细胞TH、IL-1β和TNF—α的mRNA表达水平高于正常,且与精神分裂症的-般病理症状显著相关。 相似文献
63.
64.
A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism 总被引:6,自引:0,他引:6
R. A. Lucas D. J. Gilfillan R. F. Bergstrom 《European journal of clinical pharmacology》1998,54(8):639-643
Objective: Olanzapine is a novel antipsychotic, which is effective against both the positive and negative symptoms of schizophrenia
and causes fewer extrapyramidal adverse effects than conventional antipsychotics. The purpose of the present study was to
assess the potential for a pharmacokinetic interaction between olanzapine and carbamazepine, since these agents are likely
to be used concomitantly in the treatment of manic psychotic disorder.
Method: The pharmacokinetics of two single therapeutic doses of olanzapine were determined in 11 healthy volunteers. The first dose
of olanzapine (10 mg) was taken alone and the second dose (10 mg) after 2 weeks of treatment with carbamazepine (200 mg BID).
Measurement of urinary 6-hydroxycortisol/cortisol excretion was used as an endogenous marker to confirm that induction of
CYP3A4 by carbamazepine had occurred.
Results: The dose of olanzapine given after a 2-week pre-treatment with carbamazepine was cleared more rapidly than olanzapine given
alone. Olanzapine pharmacokinetic values for Cmax and AUC were significantly lower after the second dose, the elimination half-life was significantly shorter, and the clearance
and volume of distribution were significantly increased.
Conclusion: Carbamazepine has been shown to induce several P450 cytochromes including CYP3A4 and CYP1A2. Since CYP1A2 plays a role in
the metabolic clearance of olanzapine, the interaction may be attributed to induction of CYP1A2 by carbamazepine, leading
to increased first-pass and systemic metabolism of olanzapine. The interaction is not considered to be of clinical significance
because olanzapine has a wide therapeutic index, and the changes in plasma concentration of olanzapine are within the fourfold
variation that occurs without concern for safety in a patient population.
Received: 22 July 1997 / Accepted in revised form: 1 June 1998 相似文献
65.
金励华 《中国神经精神疾病杂志》1993,(6)
患者男性,农民,22岁。一年前无意中发现吃饭用右手持筷夹菜时手抖,自己不能控制,但在田间劳动或做其他事情时如常。今年别人发现其有时头摇,在人多或情绪激动时摇动更明显,同时手抖也较较前加重,但仍不影响正常的劳动和生活。查体:一般内科检查无异常发现,神经系 相似文献
66.
Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action 总被引:1,自引:1,他引:0
Latent inhibition (LI) of a conditioned emotional response (CER) has been proposed as a quantitative measure of selective attention. We have assessed the parallels of the pharmacology of LI in rats with the clinical pharmacology of schizophrenia. Drug and vehicle treated rats were divided into groups and preexposed 20 times to cage illumination as a CS, or not preexposed. All groups were conditioned with 2 CS-footshock pairings. The following day CER, as measured by interruption of drinking in response to CS presentation, was recorded. LI was observed as a decreased CER in preexposed relative to non-preexposed animals. LI was enhanced by haloperidol 0.3 mg/kg after 7 or 14 daily treatments, but not after a single acute dose. Haloperidol doses of 0.3 and 0.03 mg/kg enhanced LI, while doses of 0.003 and 3.0 mg/kg had no effect. Haloperidol enhancement of LI was unaffected by the coadministration of the anticholinergic agent trihexyphenidyl. Enhancement of LI is exhibited by the antipsychotic drugs fluphenazine, chlorpromazine, thiothixene, thioridazine, mesoridazine, and metoclopramide but not clozapine. The non-antipsychotic drugs pentobarbital, imipramine, chlordiazepoxide, trihexyphenidyl, and promethazine failed to enhance LI. LI exhibits striking parallels to the clinical pharmacology of schizophrenia.Preliminary data were presented in part at the Society for Neuroscience Annual Meeting, Phoenix, AZ, 1989 相似文献
67.
Developing rats are far more sensitive than adults to the behavioral effects of haloperidol. The present results support the hypothesis that this change may reflect age-related changes in brain responses such as alterations in drug-receptor or drug-effector mechanisms. Dose-response studies of catalepsy and ptosis were conducted in male Sprague-Dawley rats aged 30, 56, or 100 days. Resulting dose-effect curves were approximately parallel and showed rightward shifts with highly significant progressive increases of ED50. Similar developmental decreases in drug sensitivity (3–6 ×) were found following systemic (PO or IP) administration of haloperidol or the phenothiazine neuroleptic perphenazine, which differ markedly in structure, potency, distribution, and metabolism. Age-related decreases in drug sensitivity (3–4 ×) were also found using intracerebroventricular (ICV) administration of both agents in an attempt to bypass potential pharmacokinetic influences. Since the age-dependent decrease in sensitivity to both neuroleptics was found during the rising phase of drug action (1st hour) and ranked: PO>IP>ICV, some change in absorption and distribution of both drugs may occur in addition to the apparently important maturational decrease in target-organ sensitivity indicated by the responses to direct ICV injection and by the similarity of results obtained with dissimilar agents. 相似文献
68.
L. Farde F. -A. Wiesel P. Jansson G. Uppfeldt A. Wahlen G. Sedvall 《Psychopharmacology》1988,94(1):1-7
Raclopride, a highly selective D2-dopamine receptor antagonist, was administered in doses up to 4 mg b.i.d. to ten schizophrenic patients in an open label non-comparative study lasting 4 weeks. Safety, tolerability, potential antipsychotic effect, prolactin response and drug effect on plasma homovanillic acid were evaluated. Central D2-dopamine receptor occupancy was determined by positron emission tomography (PET). No major deviations were found in biochemical and physiological safety parameters. Raclopride was well tolerated. The mean BPRS score was reduced by 55% at endpoint. In the global evaluation seven patients were very much or much improved. Extrapyramidal side effects were recorded in four patients and disappeared after dose reduction or single doses of biperiden. An increase in plasma prolactin of short duration was observed in both sexes. A significant decrease of plasma HVA was obtained after 4 weeks of treatment. In two of the patients the central D2-dopamine receptors occupancy was measured using PET. The receptor occupancy was 68 and 72% which is the same as that found in patients treated with conventional neuroleptics. 相似文献
69.
背景经济社会的发展、生活方式的转变及新型冠状病毒感染疫情的发生都对人群心身健康水平产生影响,进而可能使精神障碍的患病情况发生变化。然而,目前新疆维吾尔自治区的精神障碍流行病学调查资料尚不完善。目的 调查新疆维吾尔自治区北部(简称北疆)≥15岁人群的常见精神障碍患病率及影响因素,并同新疆维吾尔自治区南部(简称南疆)相关资料进行汇总与对比,得出全疆常见精神障碍患病情况,为制定相应的精神卫生规划提供科学依据。方法 于2021年11月至2022年7月,采用多阶段分层随机抽样法在北疆选取居民3 853例为研究对象。以社会人口学调查表、自评量表(12项一般用健康问卷、心境障碍问卷、90项症状清单等)及他评量表(汉密尔顿抑郁量表、贝克-拉范森躁狂量表、简明精神病量表等)作为调查工具,以国际疾病分类第10版(ICD-10)中的精神与行为障碍分类为诊断标准,由两名具有≥5年工作经验的精神科医师对纳入居民进行精神障碍诊断,诊断不一致者由精神科主任或副主任医师进行二次诊断。结果 北疆地区常见精神障碍时点患病率为9.71%(374/3 853),年龄调整率为10.07%;全疆常见精神障碍时点患病率为9.69%... 相似文献
70.
David de Wied Jan M. van Ree 《European archives of psychiatry and clinical neuroscience》1989,238(5-6):323-331
Summary Animal studies have demonstrated that neuropeptides modulate nervous system functions. It has been postulated that disturbances in neuropeptide systems may be aetiological factors in psychiatric and neurological disorders. Neuropeptides related to ACTH/MSH, including ORG 2766, increase motivation and attention and facilitate recovery processes after nerve damage. These peptides may be effective during the early stage of dementia. Vasopressin and related peptides improve memory processes in animals and humans. In addition, these peptides influence social behaviour, mood and addictive behaviour. The non-opioid -type endorphins have neurolepticlike activities in animals and antipsychotic effects in a category of schizophrenic patients. Peptides related to CCK have also been found to be effective in these patients. Some neuropeptides, e.g. TRH and PLG, have been reported to exert antidepressant effects. Further research may eventually produce neuropeptides with therapeutic action in psychiatric and neurological diseases.Parts of this article were presented on the occasion of the inauguration ceremony of the Department of Psychiatry of the University of Mainz on April 2 and 3, 1987 相似文献